OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

The members of the Board who served as agents
for the Corporate
Trustee
during
the financial year were
correctly diedosed as fogows:
Derek Bell Joint Chairman
Jugs Ann Gilfon Chief Executive to31st March 2D23
Anandapuram Deepak Dwarakanath Chief Medical Officer to21stSeptember 2023 /Deputy Chief Executive to
30th September 2023
Elaine Gook Interim Chief Medical Officer from 22nd September 2023
Alan Sheppard Chief People Officer to 31stAugust 2022
Neil Atkinson Managing
Director from 1st April 2023
Graham
Evans
Chief Information
Technology
Officer to31st May 2022
Levl Bucklay Chief Operating
Officer to 3Dth Apdf 2023
Stephen
Hall
Vice Chairman
and hfon-executive
Director to 31st
March 2023
Ann Baxter Vice Chair from 1 April 2023
Lfndsey Robertson Chief Nuse/Director
of Patient Safety end Quality
Linda Hunter Director of Planning
&Performance
Graham
Walton
Non-executive
Director to 17th March 2023
Christopher
Macklin
Non-executive
Director
Gglian Colquhoun Chief Informsffon
8 Technology
Offfcer from 30th May 2022 to 30th June
2023
Ken Anderson Chief fnformation 8 Technology
Offfcer from 30th October 2023
Suey Cook Chief People Office/Director
ofCorporate Affairs
Fey Scugion Norvexacutlve
Director
lsn Simpson Chair of NTH Solutions LLP and Optimus
Limited Company
(Non-
Execulive Director)
James Bromiley Norvexecutive
Director from 1st February 2023to 31stJuly 2023
Algeon Fellows Non-executive
Director
Elizabeth Bames Non-executive
Direrlor fmm 1st February 2023
Kate Hudson-Hslliday Acting Director of Finance from 1stJune 2023
Rowena Dean Acting Chief Operating
ONcer from 24th April 2023
Michaef Houghton Director ofTransformation
from 1Dth July 2023
Stuart Iivlne Director ofStrategy, Assurance
&Compliance
from
1Dlh July 2023

m E
Paxman
cooling ceps to prevent
hair loss during chemotherapy treatment 34
Anetic aid patient trolley stroke unit 7
Vien viewer flex Hasmatology 5
Benevision
N1 Monitor Stroke unit
5
Other medical eqvipmenl
57

ajor refurbishm ents
and ITequipment
purchases
during
Ihe y
ear are shown b elow:
~Edll rra
Touchscreen devices, trolley and software used by dementia patients
Refurbishment urology room
Other refurbishment
costs
15
Staff training 67
Other staff welfare 30
97

Staff lottery winnings
paid
29
Statf lottery administration costs 1
Fundralsing Events costs 18
Fundraising salary recharge costs 42
90

Funds managed by CCLA For Charities are as follows:
Equities f000
COIF Charities Investment Fund 1,414 100
Total 1,414 100

Total Total
Note Unreslrided Restricted Funds Funds
Funds Funds 2022/23 2021/22
8000 8000 8000 EDOO
Income and endowments from:
Donations 3 458 110 568 498
Legacies 3 'I61
Charitable
activities
4 3'I 3'I 41
Other trading
activities-Fundraising
Events- Staff lottery 5 5 43 48 43
Other incoming
resources
6 6 9 15 5
Investment
Income
13.3 23 18 41 41
Total incoming
resources
492 211 703 789
Expenditure
on:
Raising Funds 60 30 90 55
Charitable
activities:
Research Posts and Clinical Care 37 37 4
Pumhsse of Equipment 57 57 'ID7
Refurbishment
costs
1 14 15 22
Staff Education
and Welfare
20 77 97 70
Patient Welfare 16 25 41 41
Governance
Costs
10 23 18 41 37
Total expenditure 120 258 378 336
Net (loss)/gain
an Investments
13.1~31 ~24 ~55 118
Net income/(expenditure) before transfers 341 (71) 270 571
Transfers between
funds
16 (95) 95
Net movement
in funds
18 246 24 270 571
Fund balances brought farwsrd at 1 April 1,392 1,225 2,617 2,046
Fund balances carried forward at 31 March 'I,838 1,249 2,887 2,617
Balance Sheet as at 31 March 2023
Note Unrestricted Restricted Total at 31 Tata Iat31
Funds Funtie March 2023 March 2022
f000 f000 EOOO f000
Fixed Assets
Investments 13 695 719 1414 1469
Total fixed assets 695 719 1,414 1,469
Current Assets
Stocks
Debtors and accrued income 14 11 11 12
Cash and cash equivalents 966 009 1 555 1 241
Total current assets 966 600 1,5 1,209
Current gabilitles
Creditors: amounts falling due
within one year 15 23 70 93 111
Net current assets 943 530 1,473 1,148
Total assets lass current liabgitles 1.638 1.249 2,887 2,617
Net Assets 1,638 1,249 2,887 2,617
The funds ofthe Charity
Restricted Income funds 1,249 1,249 1,225
Unrestricted
income
funds 1,638 'i,638 1,392
Total Charity Funds 19 1,638 1,249 2,887 2,617

Note
2022I23 2021/22
6000 6000
Cash tlows from operating activitiles:
Net cash from operating activities 18 267 686
Cash flows from investing activities:
Dividends and Interest from Investmenls 13.3 41 41
Proceeds from sale ofinvestments
Net cash provided
by investing
activities
41 41
Change in cash and cash equivalents In the reporting period 308
Increase in cash and cash equivalents in the year 308 727
Cash and cash equivalents at ihe bsg!nnlng of
repcrling period 1,247 520
Total cash and cash equivalents
st the end
1,555 1,247
ofthe year

3.Voluntar y
Income
Unrestricted Restricted Total Total
Funds Funds 2022/23 2021/22
EOOD EOOD EOOD EOOD
Donations 2 97 99 91
Fundrsising Income Generated by Individuals 16 1'I 27 14
Grants Receivable 97 97 27
Corporate Donations 338 338 362
Gift Aid 5 7 4
Legacies 161
Total 458 110 568 659

The income was primarily
from the provis
ion oftraining courses
in
furtherance
ofthe
Charity's objective s.
Unrestricted Restricted Total Total
Funds Funds 2D22/23 2021/22
EOOO EOOO EOOD EOOD
Income from the provision
ofeducation and training 31 31 41
Total 31 31 41
5.Other Trading Activities
Unrestricted Restricted Total Total
Funds Funds 2022/23 2D21/22
EOOO FOOD EDOO EOOD
Staff Lottery deductions 43 43 40
Fundraising Events 5 3
Total
6. Other Incoming Resources
Unrestricted Restricted Total Total
Funds Funds 2022/23 2D21/22
EOOD EOOD EOOD EOOD
Other Income 6 9 15 5
Total 9 15 5

7.Raising F unds
2022/23 2021/22
ROOD ROOD
Staff Lottery Winnings &Admin 30 28
Fundraising Expenses 'I8 5
Fundraising Salary Costs 42 22
Total 55 55
8.Charitable activities
The Charity pursued
its
charitable activities by making grants. shown below by category.
2022/23 2021/22
EDDO EOOD
Purchase of Equipment 57 107
Research Posts and Clinical Care 37 4
Refurbishment Costs & ITEquipment 15 22
Staff Education
and Welfare
97 70
Patients Welfare 41 41
Total

10.Gov ernance
Costs
2022/23 2021/22
ROOD ROD 0
Internal audit 3 3
External audit 9 6
Governance 12
Financial administration 29 28
Total 41 37

The investment
is valued at bid price 2022/23 and
The investment
is valued at bid price 2022/23 and
The investment
is valued at bid price 2022/23 and
2021/22
13.1 Movement
In fixed asset investment
2022/23 2021/22
Total Total
6000 6000
Market value brought forward 1,469 1,351
IVionies owed by COLA for Charities 10 10
Shorl term dividends (10) ('I0)
Less disposals at carrying
Net gain on revaluation
value ~55 118
Market value at 31 March 1,414 1,469
13.2 Market value at 31 March 2022/23 2021/22
Total Total
8000 6000
Held in UK
COIF Charities
Investment
Fund 1,414 1,469
Total 1,414 1,469
2022/23 2021/22
Asset alfocation
Overseas
Equities
63.41% 64 13%
Infrastructure &Operating Assets 8.32'Yo 9.06%o
UK Equities 8.04% 8.50%
Fixed Interest 7.84%
Cash &near cash 4 76% 8.52%
Property 3.10% 458%
Contractual &Other Income 1 85% 2.76%
Private Equity &Other 2.66% 2.45o7o
Oerivatives O.D2%
100% 100%

13.3 Total gross income from invest ments
and cash on deposit
2022/23 2021/22
Total Total
ROOD ROOD
Meld in UK
Investments 41 41
Total 41 41

14.Deb tors: amounts faglng du e within one year
2022/23 2021/22
Total Total
RDOO 6000
Dividend Income 11 11
Pre payments 1
Accrued Income
Total 12
15.Creditors: amounts falling due within one year
2022/23 2021/22
Total Total
ROOD ROOD
Accruals 31 51
Deferred Income 2 4
Amounts owed to North Tees and Hartlepool NHS and
Trading Companies 60 48
Foundation
Trust
Other creditors
Total 93
There is no security for non-trading amounts owed to the Foundation Trust.
16. Transfers between funds 2022/23 2021/22
Total Total
f000 ROOD
Transfers 95

2022/23 2021/22
Total Total
6000 6000
Net movement
in funds
270 571
Loss/(Gain)
on investments
55 (118)
Deduct interest/dividends income shown
in investing
activiTies
(41) (41)
Decrease in debtors 1 268
(Decrease)/Increase in creditors (18) 6
Net cash generated from operating activities 267 686